Searched for

TELAVANT HOLDINGS

Roche buys US rights to Roivant bowel disease drug in $7.1 billion deal
Roche has announced its acquisition of Telavant, a developer of a new treatment for inflammatory bowel diseases, for an initial $7.1 billio...
23 Oct, 2023, 03.22 PM IST

Hot on Web